Steve Ryder

Steve Ryder has over 35 years of experience in the pharmaceutical industry. Steve began their career at Wyeth Ayerst Laboratories in 1982 in a Clinical role. In 1987, they moved to Pfizer, where they held a Development role. In 2008, they became President of Astellas Pharma Global Development. In 2013, they were appointed Chief Development Officer at Alexion Pharmaceuticals, Inc. In 2018, they were named Chief Medical Officer at Rallybio. Steve currently serves on the Board of Directors for Levo Therapeutics, Inc.

Steve Ryder attended Mt Sinai School of Medicine, where they obtained their Doctor of Medicine (MD) degree.